These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25772481)

  • 41. Transplantation of Human Urine-Derived Stem Cells Transfected with Pigment Epithelium-Derived Factor to Protect Erectile Function in a Rat Model of Cavernous Nerve Injury.
    Yang Q; Chen X; Zheng T; Han D; Zhang H; Shi Y; Bian J; Sun X; Xia K; Liang X; Liu G; Zhang Y; Deng C
    Cell Transplant; 2016 Nov; 25(11):1987-2001. PubMed ID: 27075964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury.
    Ouyang X; Han X; Chen Z; Fang J; Huang X; Wei H
    Stem Cell Res Ther; 2018 Sep; 9(1):246. PubMed ID: 30257719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
    Cho MC; Park K; Kim SW; Paick JS
    J Urol; 2015 May; 193(5):1716-23. PubMed ID: 25444982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury.
    Kendirci M; Trost L; Bakondi B; Whitney MJ; Hellstrom WJ; Spees JL
    J Urol; 2010 Oct; 184(4):1560-6. PubMed ID: 20728109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic treatment with a combination of hepatocyte growth factor and JNK inhibitor ameliorates cavernosal veno-occlusive dysfunction: a rat model of cavernous nerve injury.
    Lee J; Son H; Kim SW; Cho MC
    J Sex Med; 2023 May; 20(6):749-755. PubMed ID: 37037785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effect of annexin-A1 against irreversible damage to cavernous tissue after cavernous nerve injury in the rat.
    Facio FN; Burnett AL
    BJU Int; 2012 Nov; 110(9):1346-51. PubMed ID: 22520236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury.
    Song KM; Chung JS; Choi MJ; Jin HR; Yin GN; Kwon MH; Park JM; Kim WJ; Lee SJ; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2014 Jan; 11(1):51-63. PubMed ID: 24433558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat.
    Bella AJ; Hayashi N; Carrion RE; Price R; Lue TF
    J Sex Med; 2007 Mar; 4(2):341-6; discussion 346-7. PubMed ID: 17367429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury.
    Liao CH; Wu YN; Chen BH; Lin YH; Ho HO; Chiang HS
    Sci Rep; 2016 Sep; 6():33040. PubMed ID: 27625175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Exogenous hydrogen sulfide improves erectile dysfunction by inhibiting apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury].
    Zeng Q; He S; Zhong L; Wang L; Cheng F; Zhang H; Hui J; Wei A
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1329-1336. PubMed ID: 31852640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury.
    Lin H; Dhanani N; Tseng H; Souza GR; Wang G; Cao Y; Ko TC; Jiang H; Wang R
    J Urol; 2016 Mar; 195(3):788-95. PubMed ID: 26519654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing.
    Mulhall JP; Müller A; Donohue JF; Golijanin D; Tal R; Akin-Olugbade Y; Kobylarz K; Cohen-Gould L; Bennett NE; Scardino P
    J Sex Med; 2008 Jun; 5(6):1334-44. PubMed ID: 18331272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction.
    Cho MC; Lee J; Park J; Oh S; Chai JS; Son H; Paick JS; Kim SW
    Asian J Androl; 2019; 21(5):493-500. PubMed ID: 30829289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCL5 Cytokine Is a Major Factor in Platelet-Rich Plasma's Preservation of Erectile Function in Rats After Bilateral Cavernous Nerve Injury.
    Wu YN; Liao CH; Chen KC; Chiang HS
    J Sex Med; 2021 Apr; 18(4):698-710. PubMed ID: 33741291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
    Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
    J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury.
    You D; Jang MJ; Lee J; Suh N; Jeong IG; Sohn DW; Kim SW; Ahn TY; Kim CS
    Prostate; 2013 Feb; 73(3):278-86. PubMed ID: 22821215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of mesenchymal stem cells associated to matrixen on the erectile function in the rat model with bilateral cavernous nerve crushing injury.
    Kim SJ; Park SH; Sung YC; Kim SW
    Int Braz J Urol; 2012; 38(6):833-41. PubMed ID: 23302404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Tissue Sealing Sheet on Erectile Dysfunction in a Rat Model of Nerve-Sparing Radical Prostatectomy.
    Yamashita S; Fujii S; Kamiyama Y; Kawasaki Y; Izumi H; Kawamorita N; Mitsuzuka K; Adachi H; Kaiho Y; Ito A; Arai Y
    J Sex Med; 2016 Oct; 13(10):1448-54. PubMed ID: 27567074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury.
    Fandel TM; Bella AJ; Tantiwongse K; Garcia M; Nunes L; Thüroff JW; Tanagho EA; Pohl J; Lue TF
    BJU Int; 2006 Sep; 98(3):632-6. PubMed ID: 16796696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model.
    Müller A; Tal R; Donohue JF; Akin-Olugbade Y; Kobylarz K; Paduch D; Cutter SC; Mehrara BJ; Scardino PT; Mulhall JP
    J Sex Med; 2008 Mar; 5(3):562-70. PubMed ID: 18194179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.